Welcome to: Beijing Dongfang Baitai Biotechnology Co., Ltd
CN
Product introduction
Position:
Homepage
/
Product introduction/clinical
All categories

QRGANIZATIONAL STRUCTURE

北京東方百泰生(shēng)物科(kē)技股份有限公司

研發管線

腫瘤模型

美迪西已建立将近300種腫瘤評價模型,同時我們爲創新療法賦能,全面布局腫瘤免疫療法的評價和研究,已完成CAR-T,TCR-T, CAR-NK, 溶瘤病毒, 抗體(tǐ)(單抗,雙抗,多抗等),siRNA, AAV等免疫療法的模型建立及藥效評價。

腫瘤模型

美迪西已建立将近300種腫瘤評價模型,同時我們爲創新療法賦能,全面布局腫瘤免疫療法的評價和研究,已完成CAR-T,TCR-T, CAR-NK, 溶瘤病毒, 抗體(tǐ)(單抗,雙抗,多抗等),siRNA, AAV等免疫療法的模型建立及藥效評價。

腫瘤模型

美迪西已建立将近300種腫瘤評價模型,同時我們爲創新療法賦能,全面布局腫瘤免疫療法的評價和研究,已完成CAR-T,TCR-T, CAR-NK, 溶瘤病毒, 抗體(tǐ)(單抗,雙抗,多抗等),siRNA, AAV等免疫療法的模型建立及藥效評價。

腫瘤模型

美迪西已建立将近300種腫瘤評價模型,同時我們爲創新療法賦能,全面布局腫瘤免疫療法的評價和研究,已完成CAR-T,TCR-T, CAR-NK, 溶瘤病毒, 抗體(tǐ)(單抗,雙抗,多抗等),siRNA, AAV等免疫療法的模型建立及藥效評價。

腫瘤模型

美迪西已建立将近300種腫瘤評價模型,同時我們爲創新療法賦能,全面布局腫瘤免疫療法的評價和研究,已完成CAR-T,TCR-T, CAR-NK, 溶瘤病毒, 抗體(tǐ)(單抗,雙抗,多抗等),siRNA, AAV等免疫療法的模型建立及藥效評價。

産品介紹-臨床招募-Clinical recruitment

Time of issue:2022-07-11 14:49:38

Clinical recruitment

Dongfang Baitai truly take the patient's needs as the starting point. We are committed to finding the best ways to improve, control and treat disease. Through clinical trials and studies, Dongfang Baitai provides patients with more diverse, more effective and safer drug choices. Now recruit suitable patients who meet the criteria to participate in clinical trials.Recruitment information is as follows: 

 

For more information, please refer to the Drug Clinical Trial Registration and Information Publicity platform.

Name of Drug

Registration Number

Indications

Stage of trial

JY028 injection

CTR20171267

Neovascular (wet) age-related macular degeneration

Phase II clinical trial

 

JY025 injection

CTR20182451

Advanced solid tumor

Phase I clinical trial

 

JY09 injection

CTR20192166

Type 2 diabetes

Phase II clinical trial

 

JY025 injection

CTR20220059

Advanced non-small cell lung cancer

Phase I b clinical trial

 

JY025 injection

CTR20211128

Locally advanced or metastatic non-squamous non-small cell lung cancer

Phase II clinical trial

 

JY028 injection

CTR20201647

For metastatic colorectal cancer, advanced, metastatic or recurrent non-small cell lung cancer

Phase I clinical trial

 

JY028 injection

CTR20192184

Metastatic colorectal cancer; Non-small cell lung cancer

Phase I clinical trial

 

JY026 injection

CTR20192155

Rheumatoid arthritis; Ankylosing spondylitis

Phase I clinical trial

 

JY09 injection

CTR20180008

Type 2 diabetes

Phase I clinical trial

 

JY09 injection

CTR20160613

Type 2 diabetes

Phase II clinical trial

 

Follow us

1

Follow the official WeChat official account

Or search "Oriental Baitai"

More exciting waiting for you!

Address: No. 2, Rongjing East Street, Beijing Economic and Technological Development Zone
Tel.: 010-51571019
Email: ebt@east-bt.com

Copyright 2021 Beijing Dongfang Baitai Biotechnology Co., Ltd    SEO    

Beijing Dongfang Baitai Biotechnology Co., Ltd

Online customer service
Customer service hotline
010-51571019 010-51571019
Service time:
8:30 - 17:30
Customer service group:
在線客服